FA.PA.SA

Farmacéutica Paraguaya S.A. (Fapasa) is a leading pharmaceutical company based in Paraguay and a key subsidiary of the Adium Pharma group. The company specializes in the development, manufacturing, and commercialization of a broad range of pharmaceutical products, including high-quality generics and licensed innovative therapies. Fapasa operates a state-of-the-art manufacturing facility in Fernando de la Mora that complies with international Good Manufacturing Practices (GMP) standards. Through strategic partnerships with global pharmaceutical leaders like MSD and Roche, Fapasa provides the Paraguayan and Latin American markets with access to advanced treatments in oncology, cardiology, and neurology. The company is also a significant exporter, distributing its products to over 15 countries in the region. Fapasa's commitment to quality and innovation has established it as a cornerstone of the healthcare industry in Paraguay.